FDA Okays Upadacitinib for Giant Cell Arteritis ...Middle East

Medscape - News
FDA Okays Upadacitinib for Giant Cell Arteritis
This is the first and only oral JAK inhibitor indicated for giant cell arteritis, according to the manufacturer AbbVie. Medscape Medical News

Hence then, the article about fda okays upadacitinib for giant cell arteritis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Okays Upadacitinib for Giant Cell Arteritis )

Apple Storegoogle play

Last updated :

Also on site :